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Summary: The influence of pyridoxal-5'-phosphate on the activities of alanine aminotransferase and aspartate
aminotransferase from commercial test sera was investigated. Enhancement of the activity of alanine amino-
transferase by the coenzyme is about 20% when 0.1 mmol/1 of pyridoxal-S'-phosphate is added to the reaction
medium. This concentration seems sufficient for full saturation of the apoenzyme. For aspartate aminotransferase,
the enhancement of the enzymatic activity is much higher than for alanine aminotransferase and 0.1 mmol/1 of
coenzyme is not sufficient for full saturation in this case.
In order to gain more insigjht into these differences in activity in commercial test sera, human sera were freeze dried
and the aminotransferase activities determined after reconstitution. A decrease in activity of alanine aminotransferase
was observed which could not be restored to the original level by the addition of pyridoxal-S'-phosphate. Thus it
seems that freeze drying partially destroys alanine aminotransferase. After freeze drying the aspartate amino-
transferase activity is also somewhat reduced, but the addition of pyridoxal-S'-phosphate restores the activity
completely. After freeze drying the degree of enhancement of the activity by the coenzyme is therefore higher than
before freeze drying.
Comparing the results obtained from the commercial test sera and the freeze dried human sera it appears that the
freeze drying process might be a reason for the low alanine aminotransferase activities mostly observed in test sera.
The freeze drying process could also partly explain why the enhancement of the aspartate aminotransferase activity
in commercial test sera by the coenzyme is higher than in normal human sera.
In general, it seems important that manufacturers of commercial test sera should supply values for aminotransferases
which are determined in the absence and in the presence of pyridoxal-S'-phosphate.
Einfluß vori Pyridoxal-5^phösphat auf die Bestimmung von Alaninaminotransferase und Aspartataminotransferase
in kommerziellen Testseren
Zusammenfassung: Es wurde der Einfluß von PyridOxal-5'-phosphat auf die Aktivität von Alaninaminotransferase
und Aspaf tatamiriotransferase in kommerziellen Testseren untersucht. Die Zunahme der Aktivität beträgt, wenn
0,1 mmol/1 Pyridoxal-5%phosphat dem Reaktipnsgemisch zugefügt wird, etwa 20% für Alaninaminotransferase.
Diese Konzentration ist ausreichend für vollständige Sättigung des Apoenzyms. Bei Aspartataminotransferase ist die
Zunahme der Aktivität viel höher als bei Alaninaminotransferase. Zusatz von 0,1 mmol/1 Coenzym ist hier nicht ge-
nügend für vollständige Sättigung.
Um diese Unterschiede in der Aktivität vori Aminotransferase in kommerziellen Testseren zu erklären, wurden Human-
seren lyophflisiert und die Aminotransferase-Aktivitäten nach Rekönstitution bestimmt. Es wurde eine Abnahme der
Alaninamihotränsferase-Aktivität gefunden, die durch Zusatz von Pyridoxal-5'-phosphat nicht mehr zur ursprüngli-
cher Aktivität zurückgeführt werden konnte. Die Alaninarninotransferase-Aktivität wurde beim Gefriertrocknen
zum Teil zerstört. Nach Gefriertrpcknen ist die Aspartataminotransferase-Aktivität ein wenig niedriger als vorher.
Durch Zusatz von Pyridoxal-S'-phosphat konnte die Aktivität vollständig auf den ursprünglichen Wert zurückgeführt
werden. Die Stimulierung der Aktivität durch das Coenzym ist also nach Gefriertrocknen höher als vorher.
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Aus den Ergebnissen, erhalten aus den kommerziellen Seren und den gefriergetrockneten Seren, schließen wir, daß das
Gefriertrocknen eine Ursache der niedrigen Alaninaminotransferase-Aktivität sein kann, die oft in diesen Testseren
beobachtet wird. Das Gefriertrocknen kann zum Teil erklären, daß die Stimulierung der Aspartataminotransferase
durch das Coenzym in Testseren größer ist als in normalen Humanseren.
Es ist wichtig, daß die Hersteller der Testseren Werte für die AminotransferaserAktivitäten mitteilen, die mit und
ohne Pyridoxal-S'-phpsphat bestimmt sind.
Introduction
Over the past 10 years many papers have appeared
concerning the determination of the two commonly
measured serum aminotransferases. As a consequence
American, British, German and Scandinavian re-
commendations for aminotransferase determinations
have been published. The expert panel on enzymes of
the Committee on Standards of the IFCC has also
published an extensive provisional recommendation
for the aspartate aminotransferase determination (1)
(L-aspartate: 2-oxoglutarate aminotransferase,
EC 2.6.1.1). In this recommendation the addition of
pyridoxal-S'-phosphate to the reaction medium has
been described. In the Scandinavian recommendation
the addition of the coenzyme is discretionary (2).
Pyridoxal-5'-phosphate enhances serum aminotransferase
activity by recombination with the apoenzyme. In
general, an enhancement of 20—30% has been observed
for normal and pathological sera. The concentration of
the coenzyme employed in the various methods varies
from 0.1 to 0.2 mmol/1 (3-8). Usually a concentration
of 0.1 mmol/1 is used.
It is well known that most commercial test sera lack
pyridoxal-S'-phosphate. It is, therefore, understandable
that the enhancing effect of the coenzyme on these
control sera can be quite different from that of normal
human sera. Jung et al. (9) observed a stimulation of
100% for aspartate aminotransferase activity in some
control test sera using 0.2 mmol/1 pyridoxal-S'-
phosphate. Also the degree of enhancement of
aspartate aminotransferase activity is higher than for
the alanine aminotransferase (i-alanine: 2-oxoglutarate
aminotransferase, EC 2.6.1.2).
Different causes can be suggested for these phenomena.
The coenzyme may reassociate with the apoenzyme in
human sera in a manner different from that in sera of
animal origin. The difference in activation might depend
on the source of enzymes which are added to the
commercial test sera or on the method of freeze drying.
Also the possibility cannot be excluded that additives
like stabilizers can effect in some way the enzymatic
activity.
In order to gain insight into these problems we have
investigated the effect of pyridoxal-S'-phosphate on
various commercial test sera. We have also studied the
influence of freeze drying on the activity of aspartate
aminotransferase and alanine aminotransferase and the
effect of pyridoxal-5'-phosphate on both amino-
transferases from human sera.
Materials and Methods
The reconstitution of the freeze dried specimens was carried
out as prescribed by the manufacturers.
Blood was taken by venepuncture. After centrifugation the
serum samples were stored at 4 °C until the assay was carried
out. Freeze drying of human sera was carried out in counting
vials with 2 ml of serum over a period of 24 h at - 50 °C and
at 0.3 kPa. After freeze drying 2 ml of water was added to
each of the counting vials. Before and after freeze drying, the
sodium content of each of the samples was determined with a
flame photometer (IL 343) to correct for volume differences.
Aminotransferase activities were determined at 37 °C according
to the recommendation of the Committee on Enzymes of the
Scandinavian Society for Clinical Chemistry and Clinical
Physiology (2). The final reaction mixture for the determination
of the aminotransferases has been described previously (10).
0.5 ml reaction medium was added to 0.075 ml serum. After
preincubation the reaction was started by the addition of
0.05 ml 2-oxoglutarate.
All determinations were carried out at 37 °C on the Automatic
Kinetic Enzyme System (AKES, Vitatron, Dieren, The
Netherlands) at 340 nm as described previously (10). Pyridoxal-
S'-phosphate was dissolved in water and adjusted to the desired
pHwithNaOH.
Reagent blank rate and sample blank rate were, determined
under all experimental circumstances and the enzymatic
activities were corrected for these blank rates.
All enzymatic determinations with the commercial test sera
were carried out in 5 fold and the freeze drying experiments in
triplicate.
All catalytic concentrations are expressed in U/l. The percentage
increase in enzymatic activity after the addition of pyridoxal-S'-




B is enzymatic activity in the presence of pyridoxaW-phosphate
A is enzymatic activity in the absence of pyridoxal-5'-phosphate
All chemicals were reagent grade and obtained from Boehiinger,
Mannheim.
Pyridoxal-5'-phosphate was purchased from Merck, Darmstadt.
Results and Discussion
Table 1 shows the aspartate aminotransferase activity
of a number of freeze dried commercial test sera. The
sera were of human, bovine and equine origin. Generally
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Tab. 1. Stimulation of activity of aspartate aminotransferase in
freeze-dried test sera by pyridoxal-5'-phosphate.







































n: number of different test sera
Pxl-P: pyridoxal-5'-phosphate
In brackets percentage increase in activity
a high aspartate aminotransferase activity was present
in the various samples. There is a very obvious
enhancement of the enzymatic activity, when pyridoxal-
S'-phosphate is added to the reaction medium. It
appears that the addition of the coenzyme in a con-
centration of 0.1 mmol/1, which is most commonly
used, is not enough for complete saturation of the
apoenzyme under the test conditions.
In table 2 the activity of alanine aminotransferase of the
same test sera is shown. The stimulation by the
coenzyme is only about 20% and a concentration of
0.1 mmol/1 seems enough for complete saturation of
the apoenzyme.
Figure 1 shows the increase in activity of aspartate
aminotransferase and alanine aminotransferase of all
19 test sera employed after the addition of pyridoxal-
5'-phosphate to the test medium.
Tab. 2. Stimulation of activity of alanine aminotransferase in
freeze dried test sera by pyridoxal-5'-phosphate.

















































Pyridoxol- 5- phosphate added [mmol/1]
0.20
Fig. 1. Increase in enzymatic activity of aspartate aminotrans-
ferase and alanine aminotransferase from 19 different
commercial test sera by addition of pyridoxal-5-phos-
phate.
• · alanine aminotransferase ο ο aspartate
aminotransferase
2DO -
iu number of different test sera
Ρχ&Ρ: pyridoxalrS '-phosphate
In brackets percentage increase in activity
0 0.05 0.10 0.15 020 025 030
Pyridoxol-5-phosphate added immol/l)
Fig. 2. Increase in enzymatic activity of aspartate aminotrans-
ferase from different commercial test sera by addition
of pyridoxal-5'-phosphate.
It seems from this figure that even a concentration of
0.2 mmol/1 of pyridoxal-S'-phosphate is not enough to
saturate the apoenzyme of aspartate aminotransferase.
Therefore higher concentrations of the coenzyme were
subsequently employed. It can be seen in figure 2 that
a concentration of 0.2 mmol/1 of the coenzyme is
suboptimal for complete saturation of the aspartate
aminotransferase apoenzyme of the 8 test sera
investigated. A somewhat higher enhancement of the
enzymatic activity was obtained with a concentration
of 0.3 mmol/1. Higjher concentrations than 0.3 mmol/1
cannot be recommended because of the high self
absorbance of the coenzyme.
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To investigate the difference in enhancement of the
activity by pyridoxal-5'-phosphate between commercial
test sera and normal human sera, the effect of freeze
drying on normal and pathological human sera was
examined. Table 3 shows the influence of freeze drying
on the alanine aminotransferase activity. After freeze
drying, the enzymatic activity was decreased by about
15%, while the enhancing effect of pyridoxal-5'-phos-
phate was about the same, irrespective of whether or
not the sera had been freeze dried.
The effect of freeze drying on the aspartate amino-
transferase activity of human sera is shown in table 4.
The enzymatic activity in the absence of pyridoxal-5'-
phosphate is somewhat lower after freeze drying, but
addition of the coenzyme to the reaction medium
restores the activity to the original level. Thus the
percentage increase in activity after freeze drying is
higher than before.
The following general conclusions can be drawn:
Commercial test sera
1. The mean activation by pyridoxal-5'-phosphate is
much greater for aspartate aminotransferase than for
alanine aminotransferase.
2. The mean enzymatic activity of aspartate amino-
transferase is much higher than that of alanine
aminotransferase in the test sera investigated.
3. Addition of 0,1 mmol/1 pyridoxal-5'-phosphate is
not sufficient for maximal activation of aspartate
aminotransferase.
4. Addition of 0.1 mmol/1 pyridoxal-S'-phosphate is
sufficient to saturate the alanine aminotransferase
apoenzyme.
5. In general the 4 previous conclusions seem to be
valid whether human, bovine or equine test sera
were examined.
Human sera
1. A decrease in the enzymatic activity of alanine amino-
transferase is observed after freeze drying. This might
explain the low alanine aminotransferase activity in
most commercial control sera.
2. Freeze drying of serum results in a decreased activity
of alanine aminotransferase, measured in the presence
of added pyridoxal-5'-phosphate.
It seems that the apoenzyme is partially destroyed
by freeze drying, and that the addition of the
coenzyme cannot restore this decrease in activity
completely.
3. The percentage increase in alanine aminotransferase
activity is quite the same before and after freeze
drying. Bergmeyer et al (5) have observed that the
alanine aminotransferase apoenzyme formed during
Tab. 3. Influence of freeze drying on the alanine aminotransferase activity of human sera. Activities expressed in U/l.
Before freeze drying
-Pxl-P + Pxl-P Increase
After freeze drying
-Pxl-P + Pxl-P
n: number of sera investigated
Pxl-P: pyridoxal-5'-phosphate (0.1 mmol/1)


























Tab. 4. Influence of freeze drying on the aspartate aminotransferase activity of human sera. Activities expressed in U/l.
Before freeze drying





number of sera investigated
Pxl-P: pyridoxal-5'-phosphate
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dialysis of a mixture of sera from patients is denatured
and cannot be restored to its holoenzyme by adding
pyridoxal phosphate. The average activation of 27
to 29% of the alanine aminotransferase activity
remains unchanged (5). It seems that the results of
Bergmeyer et al (5) are confirmed by our experiments,
in which the sera have been freeze dried.
4. The aspartate aminotransferase activity .is far less
susceptible to the inactivation caused by the freeze
drying process. Perhaps some endogenous coenzyme
is released from the apoenzyme. Moreover, the addi-
tion of pyridoxal-5'-phosphate restores the activity
completely. The aspartate apoaminotransferase
therefore appears to remain fully intact during freeze
drying. The freeze drying process can also partly
explain why the enhancement of aspartate amino-
transferase activity in commercial test sera is higher
than in normal human sera.
In general it can be concluded that the determination
of the aminotransferases in commercial test sera
should be carried out in the presence of pyridoxal-
5'-phosphate for the measurement of maximal
activity. The freeze drying process, which is most
usual in the preparation of commercial test sera,
cannot fully explain why a high concentration of
pyridoxal-5'-phosphate is necessary for a complete
activation of the apoenzyme of aspartate amino-
transferase. We agree with the conclusions of Burger
&Potgieter (11) that manufacturers of commercial
test sera should supply values for aminotransferases,
which are determined in the absence and in the
presence of pyridoxal-5'-phosphate.
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